Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.420
+0.190 (5.88%)
At close: Nov 20, 2024, 4:00 PM
3.370
-0.050 (-1.46%)
After-hours: Nov 20, 2024, 4:29 PM EST

Kiora Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
16.02---0.012.69
Upgrade
Revenue Growth (YoY)
-----99.55%62.54%
Upgrade
Cost of Revenue
4.834.033.455.353.274.89
Upgrade
Gross Profit
11.19-4.03-3.45-5.35-3.26-2.2
Upgrade
Selling, General & Admin
5.14.667.285.224.244.41
Upgrade
Operating Expenses
5.14.667.285.224.244.41
Upgrade
Operating Income
6.09-8.69-10.73-10.57-7.51-6.61
Upgrade
Interest Expense
-0.01-0.01-0.01-0.01-0-0
Upgrade
Interest & Investment Income
0.860.170.0600.020.11
Upgrade
Other Non Operating Income (Expenses)
-0.140.03-1.44---
Upgrade
EBT Excluding Unusual Items
6.81-8.5-12.12-10.58-7.49-6.5
Upgrade
Merger & Restructuring Charges
----0.1-0.41-
Upgrade
Impairment of Goodwill
----4.04--
Upgrade
Gain (Loss) on Sale of Assets
-0.03-0.030-0.11-
Upgrade
Other Unusual Items
0.87-1.99-1.580.750.94-0.5
Upgrade
Pretax Income
5.64-12.42-13.7-13.96-6.85-7
Upgrade
Income Tax Expense
0.090.09-0.11-0.190.010.1
Upgrade
Earnings From Continuing Operations
5.55-12.51-13.58-13.77-6.86-7.1
Upgrade
Net Income
5.55-12.51-13.58-13.77-6.86-7.1
Upgrade
Preferred Dividends & Other Adjustments
-0.53----
Upgrade
Net Income to Common
5.55-13.04-13.58-13.77-6.86-7.1
Upgrade
Shares Outstanding (Basic)
31000-
Upgrade
Shares Outstanding (Diluted)
31000-
Upgrade
Shares Change (YoY)
789.70%561.21%203.73%110.04%--
Upgrade
EPS (Basic)
1.83-24.25-166.94-514.04-538.01-
Upgrade
EPS (Diluted)
1.69-24.25-166.94-514.04-538.01-
Upgrade
Free Cash Flow
8.18-9.56-10.43-10.74-7.34-8.15
Upgrade
Free Cash Flow Per Share
2.49-17.76-128.16-400.88-575.29-
Upgrade
Gross Margin
69.86%-----82.03%
Upgrade
Operating Margin
38.05%----62238.67%-246.06%
Upgrade
Profit Margin
34.64%----56901.65%-264.21%
Upgrade
Free Cash Flow Margin
51.05%----60844.56%-303.57%
Upgrade
EBITDA
6.12-8.64-10.69-10.53-7.47-6.56
Upgrade
EBITDA Margin
38.18%-----244.13%
Upgrade
D&A For EBITDA
0.020.050.040.050.030.05
Upgrade
EBIT
6.09-8.69-10.73-10.57-7.51-6.61
Upgrade
EBIT Margin
38.05%-----246.06%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.